Back to Market Feed

Product Information

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.9687 per EA under NDC 62135043390. Its NADAC has been published 177 times since Apr 5, 2023.

FDA first approved this application on Oct 11, 1985. Its Orange Book therapeutic-equivalence code is AA.

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE

butalbital, aspirin, and caffeine
$0.9687per EA
DEA Schedule CIII

Strength

325; 50; 40 mg/1; mg/1; mg/1

Manufacturer

Chartwell RX LLC

NDC

62135043390

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA086996

FDA Approved

10/11/1985

TE Code

AA

On Market Since

10/11/1985

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Cyclooxygenase Inhibitors
Decreased Platelet Aggregation
Decreased Prostaglandin Production
Methylxanthine
Nonsteroidal Anti-inflammatory Drug
Platelet Aggregation Inhibitor
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has been published 177 times since Apr 5, 2023, and over the history we have for it it has risen 35.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9687 per EA
All-time high$1.0486 (Sep 10, 2025)
All-time low$0.3623 (Nov 20, 2024)
52-week high$1.0486
52-week low$0.9687
Median price$0.8213
Average price$0.8185
Largest weekly change+59.7% (Dec 18, 2024)
Weeks tracked177
Tracking sinceApr 5, 2023

Price History

1W

-0.4%

1M

-0.4%

3M

-1.0%

6M

-1.7%

1Y

-7.6%

3Y

+30.7%

5Y

N/A

All

+35.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the butalbital, aspirin, and caffeine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

MINIPRIN EC 81 MG TABLET
Generic
49483033010•Time-Cap Labs Inc.
$0.0118
per EA
MINIPRIN EC 81 MG TABLET
Generic
49483033012•Time-Cap Labs Inc.
$0.0118
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035203•Chain Drug Marketing Association
$0.0121
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035210•Chain Drug Marketing Association
$0.0121
per EA
ST. JOSEPH ASPIRIN EC 81 MG TB
Generic
69536018112•Foundation Consumer Healthcare LLC
$0.0139
per EA
ASPIRIN EC 81 MG TABLET
Generic
00536123441•Rugby Laboratories
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904675180•Major Pharmaceuticals
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904678370•Major Pharmaceuticals
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059848•AmerisourceBergen
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059887•AmerisourceBergen
$0.0146
per EA

Frequently asked questions

What is the NADAC price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.9687 per EA (NDC 62135043390), effective Aug 19, 2026.

How has the price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has risen 35.3%. It has been tracked across 177 weekly CMS publications since Apr 5, 2023.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

Since Apr 5, 2023, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $0.3623 (Nov 20, 2024) to a high of $1.0486 (Sep 10, 2025), with a median of $0.8213 per EA.

Are there cheaper alternatives to BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE (NDC 62135043390) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.